VVOS (STOCKS)
Vivos Therapeutics, Inc. Common Stock
$1.550000
-0.120000 (-7.19%)
Prev close: $1.670000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- R. Kirk Huntsman
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $14.63M
- Employees
- 109
- P/E (TTM)
- -0.85
- P/B (TTM)
- 5.45
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.49 | $-0.52 | +0.0302 | +5.81% |
|
Jun 2025 (Q2)
|
$-0.55 | $-0.39 | -0.1573 | -40.06% |
|
Mar 2025 (Q1)
|
$-0.45 | $-0.41 | -0.0420 | -10.29% |
|
Dec 2024 (Q4)
|
$-0.28 | $-0.40 | +0.1229 | +30.50% |
Financial Statements
| Revenues | $17.32M |
| Benefits Costs and Expenses | $34.42M |
| Cost Of Revenue | $7.67M |
| Costs And Expenses | $34.42M |
| Gross Profit | $9.65M |
| Operating Expenses | $25.97M |
| Depreciation and Amortization | $1.01M |
| Other Operating Expenses | $24.86M |
| Operating Income/Loss | -$16.32M |
| Income/Loss From Continuing Operations After Tax | -$17.10M |
| Income/Loss From Continuing Operations Before Tax | -$17.10M |
| Net Income/Loss | -$17.10M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$17.10M |
| Net Income/Loss Available To Common Stockholders, Basic | -$17.10M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.77 |
| Diluted Earnings Per Share | -$1.77 |
| Basic Average Shares | 10,295,044 |
| Diluted Average Shares | 10,295,044 |
| Assets | $25.64M |
| Current Assets | $5.79M |
| Noncurrent Assets | $19.86M |
| Fixed Assets | $5.64M |
| Intangible Assets | $2.17M |
| Other Non-current Assets | $12.04M |
| Liabilities | $23.11M |
| Current Liabilities | $7.44M |
| Accounts Payable | $2.10M |
| Other Current Liabilities | $5.33M |
| Noncurrent Liabilities | $15.68M |
| Equity | $2.53M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.53M |
| Liabilities And Equity | $25.64M |
| Net Cash Flow From Operating Activities | -$14.39M |
| Net Cash Flow From Operating Activities, Continuing | -$14.39M |
| Net Cash Flow From Investing Activities | -$6.11M |
| Net Cash Flow From Investing Activities, Continuing | -$6.11M |
| Net Cash Flow From Financing Activities | $17.28M |
| Net Cash Flow From Financing Activities, Continuing | $17.28M |
| Net Cash Flow | -$3.22M |
| Net Cash Flow, Continuing | -$3.22M |
| Comprehensive Income/Loss | -$17.10M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$17.10M |
| Other Comprehensive Income/Loss | $0.00 |